Skip to main content
Loading

Mitotech

October 17, 2023
Franciscan B
Metabolic Diseases
Company Description: Mitotech Ltd is a UK-based clinical stage biotechnology company developing mitochondria targeted drugs for a variety of neurodegenerative and metabolic diseases such as Obesity, NASH, Miltiple Sclerosis, Alzheimer's and Friedreich's Ataxia. Our products are based on a calss of novel small molecules that inhibit ferroptosis at the mitochondria level.
Speakers
Anton Petrov, COO - Mitotech